Skip to main content
ConductScienceScienceDex

Vijayakanth Pagadala

NIH Rank #6420
Unclaimed recordClaim profile
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 12204069Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

NIH Funding · FY2025

Linked Award Amount
$2.1M
Full award amounts, FY2025
Award Records
2
Records listing this PI
Award-Linked Rank
#6,420
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Vijayakanth Pagadala. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Vijayakanth Pagadala as a PI. Multi-PI records show the full award amount for context.

Award organization

Organizations that administered FY2025 awards listing Vijayakanth Pagadala as a PI.

FY2025 award administered by Glycan Therapeutics Corporation (NC).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Glycan Therapeutics Corporation
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #5907
  5. 2025
    $2M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Vijayakanth Pagadala.

Katelyn Arnold
Glycan Therapeutics Corporation
1
shared award

Explore further

Find collaborators for Vijayakanth Pagadala

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →